Global Drugs for Schistosomiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Drugs for Schistosomiasis market size was valued at USD 84 million in 2023 and is forecast to a readjusted size of USD 108.3 million by 2030 with a CAGR of 3.6% during review period.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
The Global Info Research report includes an overview of the development of the Drugs for Schistosomiasis industry chain, the market status of S. haematobium (Praziquantel, Oxamniquine), S. mansoni (Praziquantel, Oxamniquine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drugs for Schistosomiasis.
Regionally, the report analyzes the Drugs for Schistosomiasis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drugs for Schistosomiasis market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drugs for Schistosomiasis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drugs for Schistosomiasis industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Praziquantel, Oxamniquine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drugs for Schistosomiasis market.
Regional Analysis: The report involves examining the Drugs for Schistosomiasis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drugs for Schistosomiasis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drugs for Schistosomiasis:
Company Analysis: Report covers individual Drugs for Schistosomiasis manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drugs for Schistosomiasis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (S. haematobium, S. mansoni).
Technology Analysis: Report covers specific technologies relevant to Drugs for Schistosomiasis. It assesses the current state, advancements, and potential future developments in Drugs for Schistosomiasis areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drugs for Schistosomiasis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Drugs for Schistosomiasis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Drugs for Schistosomiasis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drugs for Schistosomiasis, with price, sales, revenue and global market share of Drugs for Schistosomiasis from 2019 to 2024.
Chapter 3, the Drugs for Schistosomiasis competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Schistosomiasis breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Drugs for Schistosomiasis market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drugs for Schistosomiasis.
Chapter 14 and 15, to describe Drugs for Schistosomiasis sales channel, distributors, customers, research findings and conclusion.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
The Global Info Research report includes an overview of the development of the Drugs for Schistosomiasis industry chain, the market status of S. haematobium (Praziquantel, Oxamniquine), S. mansoni (Praziquantel, Oxamniquine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drugs for Schistosomiasis.
Regionally, the report analyzes the Drugs for Schistosomiasis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drugs for Schistosomiasis market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drugs for Schistosomiasis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drugs for Schistosomiasis industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Praziquantel, Oxamniquine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drugs for Schistosomiasis market.
Regional Analysis: The report involves examining the Drugs for Schistosomiasis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drugs for Schistosomiasis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drugs for Schistosomiasis:
Company Analysis: Report covers individual Drugs for Schistosomiasis manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drugs for Schistosomiasis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (S. haematobium, S. mansoni).
Technology Analysis: Report covers specific technologies relevant to Drugs for Schistosomiasis. It assesses the current state, advancements, and potential future developments in Drugs for Schistosomiasis areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drugs for Schistosomiasis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Drugs for Schistosomiasis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Praziquantel
- Oxamniquine
- Other
- S. haematobium
- S. mansoni
- S. japonicum
- S. mekongi
- S. intercalatum
- Shin Poong
- Merck
- Bayer
- EIPICO
- Chandra Bhagat Pharma
- Taj Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Drugs for Schistosomiasis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drugs for Schistosomiasis, with price, sales, revenue and global market share of Drugs for Schistosomiasis from 2019 to 2024.
Chapter 3, the Drugs for Schistosomiasis competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Schistosomiasis breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Drugs for Schistosomiasis market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drugs for Schistosomiasis.
Chapter 14 and 15, to describe Drugs for Schistosomiasis sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Drugs for Schistosomiasis
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Drugs for Schistosomiasis Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Praziquantel
1.3.3 Oxamniquine
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Drugs for Schistosomiasis Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 S. haematobium
1.4.3 S. mansoni
1.4.4 S. japonicum
1.4.5 S. mekongi
1.4.6 S. intercalatum
1.5 Global Drugs for Schistosomiasis Market Size & Forecast
1.5.1 Global Drugs for Schistosomiasis Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Drugs for Schistosomiasis Sales Quantity (2019-2030)
1.5.3 Global Drugs for Schistosomiasis Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Shin Poong
2.1.1 Shin Poong Details
2.1.2 Shin Poong Major Business
2.1.3 Shin Poong Drugs for Schistosomiasis Product and Services
2.1.4 Shin Poong Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Shin Poong Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Drugs for Schistosomiasis Product and Services
2.2.4 Merck Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Drugs for Schistosomiasis Product and Services
2.3.4 Bayer Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 EIPICO
2.4.1 EIPICO Details
2.4.2 EIPICO Major Business
2.4.3 EIPICO Drugs for Schistosomiasis Product and Services
2.4.4 EIPICO Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 EIPICO Recent Developments/Updates
2.5 Chandra Bhagat Pharma
2.5.1 Chandra Bhagat Pharma Details
2.5.2 Chandra Bhagat Pharma Major Business
2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
2.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Chandra Bhagat Pharma Recent Developments/Updates
2.6 Taj Pharmaceuticals
2.6.1 Taj Pharmaceuticals Details
2.6.2 Taj Pharmaceuticals Major Business
2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
2.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Taj Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DRUGS FOR SCHISTOSOMIASIS BY MANUFACTURER
3.1 Global Drugs for Schistosomiasis Sales Quantity by Manufacturer (2019-2024)
3.2 Global Drugs for Schistosomiasis Revenue by Manufacturer (2019-2024)
3.3 Global Drugs for Schistosomiasis Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Drugs for Schistosomiasis by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2023
3.4.2 Top 6 Drugs for Schistosomiasis Manufacturer Market Share in 2023
3.5 Drugs for Schistosomiasis Market: Overall Company Footprint Analysis
3.5.1 Drugs for Schistosomiasis Market: Region Footprint
3.5.2 Drugs for Schistosomiasis Market: Company Product Type Footprint
3.5.3 Drugs for Schistosomiasis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Drugs for Schistosomiasis Market Size by Region
4.1.1 Global Drugs for Schistosomiasis Sales Quantity by Region (2019-2030)
4.1.2 Global Drugs for Schistosomiasis Consumption Value by Region (2019-2030)
4.1.3 Global Drugs for Schistosomiasis Average Price by Region (2019-2030)
4.2 North America Drugs for Schistosomiasis Consumption Value (2019-2030)
4.3 Europe Drugs for Schistosomiasis Consumption Value (2019-2030)
4.4 Asia-Pacific Drugs for Schistosomiasis Consumption Value (2019-2030)
4.5 South America Drugs for Schistosomiasis Consumption Value (2019-2030)
4.6 Middle East and Africa Drugs for Schistosomiasis Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
5.2 Global Drugs for Schistosomiasis Consumption Value by Type (2019-2030)
5.3 Global Drugs for Schistosomiasis Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
6.2 Global Drugs for Schistosomiasis Consumption Value by Application (2019-2030)
6.3 Global Drugs for Schistosomiasis Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
7.2 North America Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
7.3 North America Drugs for Schistosomiasis Market Size by Country
7.3.1 North America Drugs for Schistosomiasis Sales Quantity by Country (2019-2030)
7.3.2 North America Drugs for Schistosomiasis Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
8.2 Europe Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
8.3 Europe Drugs for Schistosomiasis Market Size by Country
8.3.1 Europe Drugs for Schistosomiasis Sales Quantity by Country (2019-2030)
8.3.2 Europe Drugs for Schistosomiasis Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Drugs for Schistosomiasis Market Size by Region
9.3.1 Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Drugs for Schistosomiasis Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
10.2 South America Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
10.3 South America Drugs for Schistosomiasis Market Size by Country
10.3.1 South America Drugs for Schistosomiasis Sales Quantity by Country (2019-2030)
10.3.2 South America Drugs for Schistosomiasis Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Drugs for Schistosomiasis Market Size by Country
11.3.1 Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Drugs for Schistosomiasis Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Drugs for Schistosomiasis Market Drivers
12.2 Drugs for Schistosomiasis Market Restraints
12.3 Drugs for Schistosomiasis Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Drugs for Schistosomiasis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drugs for Schistosomiasis
13.3 Drugs for Schistosomiasis Production Process
13.4 Drugs for Schistosomiasis Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Drugs for Schistosomiasis Typical Distributors
14.3 Drugs for Schistosomiasis Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Drugs for Schistosomiasis
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Drugs for Schistosomiasis Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Praziquantel
1.3.3 Oxamniquine
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Drugs for Schistosomiasis Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 S. haematobium
1.4.3 S. mansoni
1.4.4 S. japonicum
1.4.5 S. mekongi
1.4.6 S. intercalatum
1.5 Global Drugs for Schistosomiasis Market Size & Forecast
1.5.1 Global Drugs for Schistosomiasis Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Drugs for Schistosomiasis Sales Quantity (2019-2030)
1.5.3 Global Drugs for Schistosomiasis Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Shin Poong
2.1.1 Shin Poong Details
2.1.2 Shin Poong Major Business
2.1.3 Shin Poong Drugs for Schistosomiasis Product and Services
2.1.4 Shin Poong Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Shin Poong Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Drugs for Schistosomiasis Product and Services
2.2.4 Merck Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Drugs for Schistosomiasis Product and Services
2.3.4 Bayer Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 EIPICO
2.4.1 EIPICO Details
2.4.2 EIPICO Major Business
2.4.3 EIPICO Drugs for Schistosomiasis Product and Services
2.4.4 EIPICO Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 EIPICO Recent Developments/Updates
2.5 Chandra Bhagat Pharma
2.5.1 Chandra Bhagat Pharma Details
2.5.2 Chandra Bhagat Pharma Major Business
2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
2.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Chandra Bhagat Pharma Recent Developments/Updates
2.6 Taj Pharmaceuticals
2.6.1 Taj Pharmaceuticals Details
2.6.2 Taj Pharmaceuticals Major Business
2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
2.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Taj Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DRUGS FOR SCHISTOSOMIASIS BY MANUFACTURER
3.1 Global Drugs for Schistosomiasis Sales Quantity by Manufacturer (2019-2024)
3.2 Global Drugs for Schistosomiasis Revenue by Manufacturer (2019-2024)
3.3 Global Drugs for Schistosomiasis Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Drugs for Schistosomiasis by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2023
3.4.2 Top 6 Drugs for Schistosomiasis Manufacturer Market Share in 2023
3.5 Drugs for Schistosomiasis Market: Overall Company Footprint Analysis
3.5.1 Drugs for Schistosomiasis Market: Region Footprint
3.5.2 Drugs for Schistosomiasis Market: Company Product Type Footprint
3.5.3 Drugs for Schistosomiasis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Drugs for Schistosomiasis Market Size by Region
4.1.1 Global Drugs for Schistosomiasis Sales Quantity by Region (2019-2030)
4.1.2 Global Drugs for Schistosomiasis Consumption Value by Region (2019-2030)
4.1.3 Global Drugs for Schistosomiasis Average Price by Region (2019-2030)
4.2 North America Drugs for Schistosomiasis Consumption Value (2019-2030)
4.3 Europe Drugs for Schistosomiasis Consumption Value (2019-2030)
4.4 Asia-Pacific Drugs for Schistosomiasis Consumption Value (2019-2030)
4.5 South America Drugs for Schistosomiasis Consumption Value (2019-2030)
4.6 Middle East and Africa Drugs for Schistosomiasis Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
5.2 Global Drugs for Schistosomiasis Consumption Value by Type (2019-2030)
5.3 Global Drugs for Schistosomiasis Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
6.2 Global Drugs for Schistosomiasis Consumption Value by Application (2019-2030)
6.3 Global Drugs for Schistosomiasis Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
7.2 North America Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
7.3 North America Drugs for Schistosomiasis Market Size by Country
7.3.1 North America Drugs for Schistosomiasis Sales Quantity by Country (2019-2030)
7.3.2 North America Drugs for Schistosomiasis Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
8.2 Europe Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
8.3 Europe Drugs for Schistosomiasis Market Size by Country
8.3.1 Europe Drugs for Schistosomiasis Sales Quantity by Country (2019-2030)
8.3.2 Europe Drugs for Schistosomiasis Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Drugs for Schistosomiasis Market Size by Region
9.3.1 Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Drugs for Schistosomiasis Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
10.2 South America Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
10.3 South America Drugs for Schistosomiasis Market Size by Country
10.3.1 South America Drugs for Schistosomiasis Sales Quantity by Country (2019-2030)
10.3.2 South America Drugs for Schistosomiasis Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Drugs for Schistosomiasis Market Size by Country
11.3.1 Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Drugs for Schistosomiasis Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Drugs for Schistosomiasis Market Drivers
12.2 Drugs for Schistosomiasis Market Restraints
12.3 Drugs for Schistosomiasis Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Drugs for Schistosomiasis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drugs for Schistosomiasis
13.3 Drugs for Schistosomiasis Production Process
13.4 Drugs for Schistosomiasis Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Drugs for Schistosomiasis Typical Distributors
14.3 Drugs for Schistosomiasis Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Drugs for Schistosomiasis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Drugs for Schistosomiasis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Shin Poong Basic Information, Manufacturing Base and Competitors
Table 4. Shin Poong Major Business
Table 5. Shin Poong Drugs for Schistosomiasis Product and Services
Table 6. Shin Poong Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Shin Poong Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Drugs for Schistosomiasis Product and Services
Table 11. Merck Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Drugs for Schistosomiasis Product and Services
Table 16. Bayer Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. EIPICO Basic Information, Manufacturing Base and Competitors
Table 19. EIPICO Major Business
Table 20. EIPICO Drugs for Schistosomiasis Product and Services
Table 21. EIPICO Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. EIPICO Recent Developments/Updates
Table 23. Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Chandra Bhagat Pharma Major Business
Table 25. Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
Table 26. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Chandra Bhagat Pharma Recent Developments/Updates
Table 28. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Taj Pharmaceuticals Major Business
Table 30. Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
Table 31. Taj Pharmaceuticals Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Taj Pharmaceuticals Recent Developments/Updates
Table 33. Global Drugs for Schistosomiasis Sales Quantity by Manufacturer (2019-2024) & (M Units)
Table 34. Global Drugs for Schistosomiasis Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Drugs for Schistosomiasis Average Price by Manufacturer (2019-2024) & (USD/K Units)
Table 36. Market Position of Manufacturers in Drugs for Schistosomiasis, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Drugs for Schistosomiasis Production Site of Key Manufacturer
Table 38. Drugs for Schistosomiasis Market: Company Product Type Footprint
Table 39. Drugs for Schistosomiasis Market: Company Product Application Footprint
Table 40. Drugs for Schistosomiasis New Market Entrants and Barriers to Market Entry
Table 41. Drugs for Schistosomiasis Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Drugs for Schistosomiasis Sales Quantity by Region (2019-2024) & (M Units)
Table 43. Global Drugs for Schistosomiasis Sales Quantity by Region (2025-2030) & (M Units)
Table 44. Global Drugs for Schistosomiasis Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Drugs for Schistosomiasis Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Drugs for Schistosomiasis Average Price by Region (2019-2024) & (USD/K Units)
Table 47. Global Drugs for Schistosomiasis Average Price by Region (2025-2030) & (USD/K Units)
Table 48. Global Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 49. Global Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 50. Global Drugs for Schistosomiasis Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Drugs for Schistosomiasis Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Drugs for Schistosomiasis Average Price by Type (2019-2024) & (USD/K Units)
Table 53. Global Drugs for Schistosomiasis Average Price by Type (2025-2030) & (USD/K Units)
Table 54. Global Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 55. Global Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 56. Global Drugs for Schistosomiasis Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Drugs for Schistosomiasis Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Drugs for Schistosomiasis Average Price by Application (2019-2024) & (USD/K Units)
Table 59. Global Drugs for Schistosomiasis Average Price by Application (2025-2030) & (USD/K Units)
Table 60. North America Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 61. North America Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 62. North America Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 63. North America Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 64. North America Drugs for Schistosomiasis Sales Quantity by Country (2019-2024) & (M Units)
Table 65. North America Drugs for Schistosomiasis Sales Quantity by Country (2025-2030) & (M Units)
Table 66. North America Drugs for Schistosomiasis Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Drugs for Schistosomiasis Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 69. Europe Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 70. Europe Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 71. Europe Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 72. Europe Drugs for Schistosomiasis Sales Quantity by Country (2019-2024) & (M Units)
Table 73. Europe Drugs for Schistosomiasis Sales Quantity by Country (2025-2030) & (M Units)
Table 74. Europe Drugs for Schistosomiasis Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Drugs for Schistosomiasis Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 77. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 78. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 79. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 80. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Region (2019-2024) & (M Units)
Table 81. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Region (2025-2030) & (M Units)
Table 82. Asia-Pacific Drugs for Schistosomiasis Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Drugs for Schistosomiasis Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 85. South America Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 86. South America Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 87. South America Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 88. South America Drugs for Schistosomiasis Sales Quantity by Country (2019-2024) & (M Units)
Table 89. South America Drugs for Schistosomiasis Sales Quantity by Country (2025-2030) & (M Units)
Table 90. South America Drugs for Schistosomiasis Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Drugs for Schistosomiasis Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 93. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 94. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 95. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 96. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Region (2019-2024) & (M Units)
Table 97. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Region (2025-2030) & (M Units)
Table 98. Middle East & Africa Drugs for Schistosomiasis Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Drugs for Schistosomiasis Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Drugs for Schistosomiasis Raw Material
Table 101. Key Manufacturers of Drugs for Schistosomiasis Raw Materials
Table 102. Drugs for Schistosomiasis Typical Distributors
Table 103. Drugs for Schistosomiasis Typical Customers
Table 1. Global Drugs for Schistosomiasis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Drugs for Schistosomiasis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Shin Poong Basic Information, Manufacturing Base and Competitors
Table 4. Shin Poong Major Business
Table 5. Shin Poong Drugs for Schistosomiasis Product and Services
Table 6. Shin Poong Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Shin Poong Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Drugs for Schistosomiasis Product and Services
Table 11. Merck Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Drugs for Schistosomiasis Product and Services
Table 16. Bayer Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. EIPICO Basic Information, Manufacturing Base and Competitors
Table 19. EIPICO Major Business
Table 20. EIPICO Drugs for Schistosomiasis Product and Services
Table 21. EIPICO Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. EIPICO Recent Developments/Updates
Table 23. Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Chandra Bhagat Pharma Major Business
Table 25. Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
Table 26. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Chandra Bhagat Pharma Recent Developments/Updates
Table 28. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Taj Pharmaceuticals Major Business
Table 30. Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
Table 31. Taj Pharmaceuticals Drugs for Schistosomiasis Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Taj Pharmaceuticals Recent Developments/Updates
Table 33. Global Drugs for Schistosomiasis Sales Quantity by Manufacturer (2019-2024) & (M Units)
Table 34. Global Drugs for Schistosomiasis Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Drugs for Schistosomiasis Average Price by Manufacturer (2019-2024) & (USD/K Units)
Table 36. Market Position of Manufacturers in Drugs for Schistosomiasis, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Drugs for Schistosomiasis Production Site of Key Manufacturer
Table 38. Drugs for Schistosomiasis Market: Company Product Type Footprint
Table 39. Drugs for Schistosomiasis Market: Company Product Application Footprint
Table 40. Drugs for Schistosomiasis New Market Entrants and Barriers to Market Entry
Table 41. Drugs for Schistosomiasis Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Drugs for Schistosomiasis Sales Quantity by Region (2019-2024) & (M Units)
Table 43. Global Drugs for Schistosomiasis Sales Quantity by Region (2025-2030) & (M Units)
Table 44. Global Drugs for Schistosomiasis Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Drugs for Schistosomiasis Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Drugs for Schistosomiasis Average Price by Region (2019-2024) & (USD/K Units)
Table 47. Global Drugs for Schistosomiasis Average Price by Region (2025-2030) & (USD/K Units)
Table 48. Global Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 49. Global Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 50. Global Drugs for Schistosomiasis Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Drugs for Schistosomiasis Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Drugs for Schistosomiasis Average Price by Type (2019-2024) & (USD/K Units)
Table 53. Global Drugs for Schistosomiasis Average Price by Type (2025-2030) & (USD/K Units)
Table 54. Global Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 55. Global Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 56. Global Drugs for Schistosomiasis Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Drugs for Schistosomiasis Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Drugs for Schistosomiasis Average Price by Application (2019-2024) & (USD/K Units)
Table 59. Global Drugs for Schistosomiasis Average Price by Application (2025-2030) & (USD/K Units)
Table 60. North America Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 61. North America Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 62. North America Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 63. North America Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 64. North America Drugs for Schistosomiasis Sales Quantity by Country (2019-2024) & (M Units)
Table 65. North America Drugs for Schistosomiasis Sales Quantity by Country (2025-2030) & (M Units)
Table 66. North America Drugs for Schistosomiasis Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Drugs for Schistosomiasis Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 69. Europe Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 70. Europe Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 71. Europe Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 72. Europe Drugs for Schistosomiasis Sales Quantity by Country (2019-2024) & (M Units)
Table 73. Europe Drugs for Schistosomiasis Sales Quantity by Country (2025-2030) & (M Units)
Table 74. Europe Drugs for Schistosomiasis Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Drugs for Schistosomiasis Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 77. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 78. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 79. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 80. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Region (2019-2024) & (M Units)
Table 81. Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Region (2025-2030) & (M Units)
Table 82. Asia-Pacific Drugs for Schistosomiasis Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Drugs for Schistosomiasis Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 85. South America Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 86. South America Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 87. South America Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 88. South America Drugs for Schistosomiasis Sales Quantity by Country (2019-2024) & (M Units)
Table 89. South America Drugs for Schistosomiasis Sales Quantity by Country (2025-2030) & (M Units)
Table 90. South America Drugs for Schistosomiasis Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Drugs for Schistosomiasis Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Type (2019-2024) & (M Units)
Table 93. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Type (2025-2030) & (M Units)
Table 94. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Application (2019-2024) & (M Units)
Table 95. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Application (2025-2030) & (M Units)
Table 96. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Region (2019-2024) & (M Units)
Table 97. Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Region (2025-2030) & (M Units)
Table 98. Middle East & Africa Drugs for Schistosomiasis Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Drugs for Schistosomiasis Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Drugs for Schistosomiasis Raw Material
Table 101. Key Manufacturers of Drugs for Schistosomiasis Raw Materials
Table 102. Drugs for Schistosomiasis Typical Distributors
Table 103. Drugs for Schistosomiasis Typical Customers
LIST OF FIGURES
Figure 1. Drugs for Schistosomiasis Picture
Figure 2. Global Drugs for Schistosomiasis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Drugs for Schistosomiasis Consumption Value Market Share by Type in 2023
Figure 4. Praziquantel Examples
Figure 5. Oxamniquine Examples
Figure 6. Other Examples
Figure 7. Global Drugs for Schistosomiasis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Drugs for Schistosomiasis Consumption Value Market Share by Application in 2023
Figure 9. S. haematobium Examples
Figure 10. S. mansoni Examples
Figure 11. S. japonicum Examples
Figure 12. S. mekongi Examples
Figure 13. S. intercalatum Examples
Figure 14. Global Drugs for Schistosomiasis Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Drugs for Schistosomiasis Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Drugs for Schistosomiasis Sales Quantity (2019-2030) & (M Units)
Figure 17. Global Drugs for Schistosomiasis Average Price (2019-2030) & (USD/K Units)
Figure 18. Global Drugs for Schistosomiasis Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Drugs for Schistosomiasis Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Drugs for Schistosomiasis by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Drugs for Schistosomiasis Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Drugs for Schistosomiasis Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Drugs for Schistosomiasis Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Drugs for Schistosomiasis Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Drugs for Schistosomiasis Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Drugs for Schistosomiasis Average Price by Type (2019-2030) & (USD/K Units)
Figure 33. Global Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Drugs for Schistosomiasis Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Drugs for Schistosomiasis Average Price by Application (2019-2030) & (USD/K Units)
Figure 36. North America Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Drugs for Schistosomiasis Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Drugs for Schistosomiasis Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Drugs for Schistosomiasis Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Drugs for Schistosomiasis Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Drugs for Schistosomiasis Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Drugs for Schistosomiasis Consumption Value Market Share by Region (2019-2030)
Figure 56. China Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Drugs for Schistosomiasis Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Drugs for Schistosomiasis Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Drugs for Schistosomiasis Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Drugs for Schistosomiasis Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Drugs for Schistosomiasis Market Drivers
Figure 77. Drugs for Schistosomiasis Market Restraints
Figure 78. Drugs for Schistosomiasis Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Drugs for Schistosomiasis in 2023
Figure 81. Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure 82. Drugs for Schistosomiasis Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Drugs for Schistosomiasis Picture
Figure 2. Global Drugs for Schistosomiasis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Drugs for Schistosomiasis Consumption Value Market Share by Type in 2023
Figure 4. Praziquantel Examples
Figure 5. Oxamniquine Examples
Figure 6. Other Examples
Figure 7. Global Drugs for Schistosomiasis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Drugs for Schistosomiasis Consumption Value Market Share by Application in 2023
Figure 9. S. haematobium Examples
Figure 10. S. mansoni Examples
Figure 11. S. japonicum Examples
Figure 12. S. mekongi Examples
Figure 13. S. intercalatum Examples
Figure 14. Global Drugs for Schistosomiasis Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Drugs for Schistosomiasis Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Drugs for Schistosomiasis Sales Quantity (2019-2030) & (M Units)
Figure 17. Global Drugs for Schistosomiasis Average Price (2019-2030) & (USD/K Units)
Figure 18. Global Drugs for Schistosomiasis Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Drugs for Schistosomiasis Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Drugs for Schistosomiasis by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Drugs for Schistosomiasis Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Drugs for Schistosomiasis Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Drugs for Schistosomiasis Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Drugs for Schistosomiasis Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Drugs for Schistosomiasis Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Drugs for Schistosomiasis Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Drugs for Schistosomiasis Average Price by Type (2019-2030) & (USD/K Units)
Figure 33. Global Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Drugs for Schistosomiasis Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Drugs for Schistosomiasis Average Price by Application (2019-2030) & (USD/K Units)
Figure 36. North America Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Drugs for Schistosomiasis Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Drugs for Schistosomiasis Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Drugs for Schistosomiasis Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Drugs for Schistosomiasis Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Drugs for Schistosomiasis Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Drugs for Schistosomiasis Consumption Value Market Share by Region (2019-2030)
Figure 56. China Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Drugs for Schistosomiasis Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Drugs for Schistosomiasis Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Drugs for Schistosomiasis Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Drugs for Schistosomiasis Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Drugs for Schistosomiasis Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Drugs for Schistosomiasis Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Drugs for Schistosomiasis Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Drugs for Schistosomiasis Market Drivers
Figure 77. Drugs for Schistosomiasis Market Restraints
Figure 78. Drugs for Schistosomiasis Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Drugs for Schistosomiasis in 2023
Figure 81. Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure 82. Drugs for Schistosomiasis Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
